TP53 and colonic neoplasm: In summary, this is the first evidence that PAK4 increased G6PD activity via enhancing Mdm2-mediated p53 ubiquitination degradation, and thus promoted the glucose intake, NADPH, palmitic acid, cholesterol and other metabolites production of colon cancer cells, leading to the increased colon cancer cell growth.